PLAY PODCASTS
Providing Options for PrEP Reengagement: Strategies to Support PrEP Persistence and Reengagement
Episode 362

Providing Options for PrEP Reengagement: Strategies to Support PrEP Persistence and Reengagement

Hear from Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, in this case-based discussion of the data and recommendations for providing HIV prevention options as a strategy to support PrEP persistence and engagement.

Decera Clinical Education Infectious Disease Podcast · Kevin Astle PharmD BCPS BCACP AAHIVP CDCES

December 15, 202316m 11s

Audio is streamed directly from the publisher (afp-928689-injected.calisto.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

In this episode, Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES, discusses data and recommendations for providing HIV prevention options as a strategy to support PrEP persistence and engagement, including: 

  • Postexposure prophylaxis (PEP) recommendations and the data for PEP-in-Pocket
  • Offering PrEP to everyone who receives PEP
  • Currently recommended PrEP options and the safety and adverse event considerations with each option
  • Monitoring recommendations for the different PrEP options
  • The importance of proactively addressing PrEP safety concerns that could lead to PrEP discontinuation

Faculty

Kevin Astle, PharmD, BCPS, BCACP, AAHIVP, CDCES
Assistant Professor
Pharmacotherapeutics and Clinical Research
University of South Florida Taneja College of Medicine
Tampa, Florida

Follow along with the slides:
bit.ly/48cULUN

Link to full program:
bit.ly/3ZlICsL


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Topics

renal functioncabotegravirpersistenceevent-drivennondailycabpep-in-pocket2-1-1preexposure prophylaxispost-exposure prophylaxis on-demandprepweight gainpepbmdemtricitabinebone mineral densityengagementftc/tdfpipkevin astleftc/tafadherencetenofovir